NASDAQ:OPNT

Opiant Pharmaceuticals (OPNT) Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: $20.03
▼
$21.10
52-Week Range: N/A

Volume: 562,700 shs
Average Volume: 77,920 shs
Market Capitalization: $108.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Analyst Ratings Earnings Financials Insider Trades Institutional Ownership Headlines Short Interest Social Media

Current Insider Ownership Percentage: 25.15%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $63,289.28
Number Of Insiders Selling (Last 12 Months): 7
Amount Of Insider Selling (Last 12 Months): $602,902.73

OPNT Insider Buying and Selling by Quarter

Get OPNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Opiant Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Opiant Pharmaceuticals Insider Trades History

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/27/2023	Brian Gorman	General Counsel	Sell	444	$20.26	$8,995.44	31,990
1/27/2023	David D O'toole	CFO	Sell	541	$20.26	$10,960.66	34,248
1/27/2023	Mark Jason Heath Ellison	Insider	Sell	610	$20.26	$12,358.60	18,751
1/27/2023	Roger Crystal	CEO	Sell	1,358	$20.26	$27,513.08	75,339
1/9/2023	David D O'toole	CFO	Sell	415	$20.20	$8,383.00	34,789
1/9/2023	Mark Jason Heath Ellison	Insider	Sell	469	$20.20	$9,473.80	19,361

1/9/2023	Roger Crystal	CEO	Sell	1,183	$20.20	$23,896.60	76,697
1/5/2023	Brian Gorman	General Counsel	Sell	1,313	$20.20	$26,522.60	32,434
1/5/2023	David D O'toole	CFO	Sell	1,600	$20.20	$32,320.00	35,204
1/5/2023	Mark Jason Heath Ellison	Insider	Sell	1,806	$20.20	$36,481.20	19,830
1/5/2023	Roger Crystal	CEO	Sell	5,029	$20.20	$101,585.80	77,880
7/20/2022	Matthew R Ruth	Insider	Sell	1,084	$10.62	$11,512.08	29,916
7/14/2022	Brian Gorman	General Counsel	Sell	691	$11.16	$7,711.56	33,747
7/14/2022	David D O'toole	CFO	Sell	779	$11.10	$8,646.90	36,804
7/14/2022	Phil Skolnick	Insider	Sell	627	$11.85	$7,429.95	23,818
7/14/2022	Roger Crystal	CEO	Sell	2,246	$11.11	$24,953.06	82,909
6/15/2022	Michael Sinclair	Director	Sell	900	$10.60	$9,540.00	19,220
6/13/2022	Craig A Collard	Director	Buy	4,037	$10.94	$44,164.78	53,822
6/10/2022	Craig A Collard	Director	Buy	1,663	$11.50	$19,124.50	49,785
6/6/2022	Michael Sinclair	Director	Sell	7,688	$12.94	$99,482.72	41,532
6/2/2022	Michael Sinclair	Director	Sell	9,736	$13.88	$135,135.68	59,484

(Data available from 1/1/2013 forward)

OPNT Insider Trading Activity - Frequently Asked Questions

Who is on Opiant Pharmaceuticals's Insider Roster?: The list of insiders at Opiant Pharmaceuticals includes Brian Gorman, Craig A Collard, David D O'toole, Gabrielle Alison Silver, Mark Jason Heath Ellison, Matthew R Ruth, Michael Sinclair, Phil Skolnick, Roger Crystal, and Thomas T Thomas. Learn more on insiders at OPNT.
What percentage of Opiant Pharmaceuticals stock is owned by insiders?: 25.15% of Opiant Pharmaceuticals stock is owned by insiders. Learn more on OPNT's insider holdings.
Which Opiant Pharmaceuticals insiders have been buying company stock?: The following insiders have purchased OPNT shares in the last 24 months: Craig A Collard ($63,289.28), David D O'toole ($13,052.00), and Matthew R Ruth ($34,680.00).

How much insider buying is happening at Opiant Pharmaceuticals?: Insiders have purchased a total of 11,000 OPNT shares in the last 24 months for a total of $156,346.28 bought.
Which Opiant Pharmaceuticals insiders have been selling company stock?: The following insiders have sold OPNT shares in the last 24 months: Brian Gorman ($43,229.60), David D O'toole ($73,529.76), Mark Jason Heath Ellison ($58,313.60), Matthew R Ruth ($11,512.08), Michael Sinclair ($2,057,156.01), Phil Skolnick ($58,925.02), Roger Crystal ($262,376.21), and Thomas T Thomas ($20,043.72).
How much insider selling is happening at Opiant Pharmaceuticals?: Insiders have sold a total of 160,131 Opiant Pharmaceuticals shares in the last 24 months for a total of $2,585,086.00 sold.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:OPNT) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Opiant Pharmaceuticals (OPNT) Insider Trading & Ownership

OPNT Insider Buying and Selling by Quarter

Opiant Pharmaceuticals Insider Trades History

OPNT Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Opiant Pharmaceuticals (OPNT) Insider Trading & Ownership

Opiant Pharmaceuticals (NASDAQ:OPNT) Insider Buying and Selling Activity

OPNT Insider Buying and Selling by Quarter

Opiant Pharmaceuticals Insider Trades History

OPNT Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat